Welkom bij Campus Sanofi Nederland
- Artikel
- Campus Sanofi
- 19 mrt 2024
Een platform voor beroepsbeoefenaren om betrouwbare en relevante informatie over onze medicijnen en therapieën te vinden.
InloggenWetenschappelijk nieuws
Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk
People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.1 The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.2,3
Bekijk meer
Understanding Autoimmune T1D & The Value of Early Detection
Autoimmune Type 1 Diabetes (T1D) can be detected through islet autoantibody testing years before symptoms appear.1-2 The video here explains how the condition progresses silently through presymptomatic stages, with beta cell destruction occurring long before symptom onset and clinical diagnosis.4-8
Bekijk meer
When a Child Gets Autoimmune Type 1 Diabetes
Parent's experiences of stage 3 diagnosis of T1D.
Bekijk meer
